The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure
The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure have?
The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure has 32 citations in the OpenAlex counts ScholarIQ stores.
When was The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure published?
The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure has 2020 year in the ScholarIQ index.
What is the open-access status of The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure?
The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure has green oa status in the ScholarIQ index.
What is the DOI of The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure?
The DOI for The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure is on the source record.
What is the PMID of The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure?
The PMID for The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure is on the source record.
What is the OpenAlex record for The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure?
The OpenAlex for The mitochondrial-targeted peptide SBT-20 ameliorates inflammation and oxidative stress in chronic renal failure is on the source record.